Doctor profile · Federal record
Dr. CINDY LI, DO
Dermatology Physician (CMS: DERMATOLOGY) · Dermatology Physician · NEW YORK, NY
- NPI 1265509111
- Accepts Medicare
- 33 yrs in practice
- Licensed in 2 states
- Female
- Solo practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
86 BOWERY FL 3
NEW YORK, NY 100134615
(212) 226-4890 - Additional location
-
1011 Baldwin Park Blvd
Baldwin Park, CA 917065806
(626) 851-1011
Credentials & registration
- NPI registered
- November 2006 — 20 yrs on file
- Profile last updated
- May 18, 2020
- Year of graduation
- 1993 — 33 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (2)
- New York #286874 · California #20A7655
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1265509111. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,107
Distinct HCPCS
10
Medicare allowed
$80,545
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 278 | 51 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 231 | 180 | $100 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 101 | 77 | $63 | |
17000 |
Destruction of precancer skin growth, 1 growth | 100 | 74 | $67 | |
96910 |
Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 94 | 11 | $140 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 80 | 80 | $123 | |
17110 |
Destruction of skin growth, 1-14 growths | 63 | 56 | $129 | |
11102 |
Biopsy of related skin growth, first growth | 60 | 56 | $107 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 55 | 11 | $1 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 22 | 22 | $78 |
In context: peer comparison
Among 139 peers in this city , average services per provider: 182. This provider delivers 6.1× the peer median.Open Payments
Industry payments received
All-time total
$3,616
Transactions
234
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 29 | $602.70 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 27 | $487.59 | |
| E.R. Squibb & Sons, L.L.C. | 30 | $382.78 | |
| Lilly USA, LLC | 17 | $305.63 | |
| PFIZER INC. | 20 | $276.59 | |
| Amgen Inc. | 15 | $225.56 | |
| Incyte Corporation | 45 | $218.20 | |
| Arcutis Biotherapeutics, Inc. | 14 | $207.15 | |
| Janssen Biotech, Inc. | 13 | $205.81 | |
| Novo Nordisk Inc | 2 | $124.72 | |
| Melinta Therapeutics, LLC | 5 | $122.91 | |
| Novartis Pharmaceuticals Corporation | 5 | $91.93 | |
| Dermavant Sciences, Inc. | 5 | $75.74 | |
| Galderma Laboratories, L.P. | 4 | $64.54 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $53.14 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
251
Patients
184
Total drug cost
$7,243
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 60 | 55 | $529 |
| Ketoconazole | Generic | 31 | 26 | $834 |
| Hydrocortisone | Generic | 30 | 30 | $171 |
| Clindamycin Phosphate | Generic | 24 | 13 | $1,027 |
| Clobetasol Propionate | Generic | 22 | 19 | $1,913 |
| Mometasone Furoate | Generic | 19 | 12 | $519 |
| Metronidazole | Generic | 18 | 0 | $1,055 |
| Mupirocin | Generic | 17 | 13 | $175 |
| Cephalexin | Generic | 16 | 16 | $69 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 14 | 0 | $951 |